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ABSTRACT
Introduction  Hypoxia is a microenvironmental feature 
in the inﬂ  amed joint, which promotes survival advantage 
for cells. The aim of this study was to examine the 
relationship of partial oxygen pressure in the synovial 
tissue (tPO2) in patients with inﬂ  ammatory arthritis with 
macroscopic/microscopic inﬂ  ammation and local levels of 
proinﬂ  ammatory mediators.
Methods  Patients with inﬂ  ammatory arthritis underwent 
full clinical assessment and video arthroscopy to quantify 
macroscopic synovitis and measure synovial tPO2 under 
direct visualisation. Cell speciﬁ  c markers (CD3 (T cells), 
CD68 (macrophages), Ki67 (cell proliferation) and terminal 
deoxynucleotidyl transferase dUTP nick end labelling 
(cell apoptosis)) were quantiﬁ  ed by immunohistology. 
In vitro migration was assessed in primary and normal 
synoviocytes (synovial ﬁ  broblast cells (SFCs)) using a 
wound repair scratch assay. Levels of tumour necrosis 
factor α (TNFα), interleukin 1β (IL1β), interferon γ (IFNγ), 
IL6, macrophage inﬂ  ammatory protein 3α (MIP3α) and 
IL8 were quantiﬁ  ed, in matched serum and synovial ﬂ  uid, 
by multiplex cytokine assay and ELISA.
Results  The tPO2 was 22.5 (range 3.2–54.1) mm Hg 
and correlated inversely with macroscopic synovitis 
(r=−0.421, p=0.02), sublining CD3 cells (−0.611, 
p<0.01) and sublining CD68 cells (r=−0.615, 
p<0.001). No relationship with cell proliferation or 
apoptosis was found. Primary and normal SFCs exposed 
to 1% and 3% oxygen (reﬂ  ecting the median tPO2 in vivo) 
induced cell migration. This was coupled with signiﬁ  cantly 
higher levels of synovial ﬂ  uid tumour necrosis factor α 
(TNFα), IL1β, IFNγ and MIP3α in patients with tPO2 <20 
mm Hg (all p values <0.05).
Conclusions  This is the ﬁ  rst study to show a direct 
in vivo correlation between synovial tPO2, inﬂ  ammation 
and cell migration, thus it is proposed that hypoxia is a 
possible primary driver of inﬂ  ammatory processes in the 
arthritic joint.
INTRODUCTION
Inﬂ   ammatory arthritides, such as rheumatoid 
arthritis (RA) and psoriatic arthritis (PsA), are pro-
gressive diseases together affecting up to 3% of 
the population.1 2 A critical early event is angio-
genesis, providing for increased leucocyte migra-
tion transforming the synovial tissue (ST) into an 
invasive ‘pannus’ resulting in cartilage and bone 
  destruction.3 4
A signiﬁ  cant increase in ST blood vessel number 
has been described, macroscopically and micro-
scopically, in RA and PsA, associated with differ-
ential vascular morphology.5–7 The early vascular 
changes are accompanied by increased recruitment 
of macrophages and synovial ﬁ  broblast cells (SFCs) 
in the lining layer,8 along with inﬁ   ltration of T, 
B and plasma cells.9 Lining layer SFCs undergo 
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phenotypic changes as they invade adjacent car-
tilage and bone, while RA SFCs can signiﬁ  cantly 
promote endothelial cell activation and leucocyte 
recruitment compared to normal or osteoarthritis 
(OA) SFCs.10 11 The precise mechanisms involved 
in regulation of persistent inﬁ  ltration and invasion 
are unclear, however high levels of cytokines and 
impaired apoptotic pathways in the microenviron-
ment are implicated.12–14
Despite increased vascular supply there is a fail-
ure to restore tissue oxygen homeostasis perhaps 
due to an expanding synovium and increased 
metabolic activity resulting in a hypoxic environ-
ment.15 16 Previous studies have demonstrated 
that the RA joint cavity is hypoxic, however the 
majority of studies have only measured oxygen 
tension indirectly in synovial ﬂ  uid (SF).17 18 In ani-
mal models of arthritis pO2 levels may be as low 
as 10 mm  Hg.19 20 Recently, hypoxia has been 
demonstrated in patients with RA undergoing sur-
gery for tendon rupture.21 Increased expression of 
hypoxia-inducible factor 1α (HIF1α), a key tran-
scription factor in the cellular response, supports a 
role for hypoxia in the pathogenesis of inﬂ  amma-
tory arthritis.22 Hypoxia, in vitro, is an important 
regulator of angiogenesis, migration, cell survival 
pathways and matrix degradation.23–25
Recently we have described profound hypoxia in 
inﬂ  amed synovial membrane using a novel oxygen 
sensing probe in vivo.26 27 Tissue oxygen pressure 
(tPO2) in vivo was strongly associated with lipid 
peroxidation, increased vascularity, altered blood 
vessel stability and increased perivascular DNA 
damage.26 27 In this study we extend our observa-
tions to establish for the ﬁ  rst time a direct relation-
ship between tPO2 levels and joint inﬂ  ammation, 
speciﬁ  cally T cell and macrophage inﬁ  ltrates and 
proinﬂ  ammatory cytokine expression.
MATERIALS AND METHODS
Patient selection and arthroscopy
Patients were recruited from the Department of 
Rheumatology, St Vincent’s University Hospital. 
Patients with RA and PsA, fulﬁ  lling the American 
College of Rheumatology28 and Classiﬁ  cation  of 
Psoriatic Arthritis criteria,29 respectively, were 
recruited. Normal synovium was obtained from 
two healthy controls. All participants gave fully 
informed consent. Patients had active disease 
despite disease-modifying antirheumatic drugs, 
had at least one inﬂ   amed knee joint and were 
due to commence biological treatment. Clinical 
and laboratory assessment included tender and 
swollen joint count, rheumatoid factor, anti-cyclic 
citrullinated peptide (anti-CCP) antibody, erythro-
cyte sedimentation rate (ESR), C reactive protein Extended report
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(CRP) and global health visual analogue scale (VAS) obtained on 
the same day prior to arthroscopy.
Arthroscopy of the inﬂ   amed knee was performed under 
local anaesthetic, using a 2.7 mm needle arthroscope (Richard 
Wolf, Illinois, USA) and macroscopic synovitis, vascularity and 
chondropathy were scored on a VAS (0–100 mm) as previously 
described.30 ST biopsies were obtained by 2 mm grasping for-
ceps, and subsequently embedded in optimal cutting tempera-
ture (OCT) compound and parafﬁ  n. Matching serum and SF 
was collected immediately before arthroscopy and stored at 
−80°C. Oxygen partial pressure was measured in the ST lining 
using a LICOX combined pO2 and temperature probe (Integra 
Life Sciences, Plainsboro, New Jersey, USA) under direct visu-
alisation as recently described26 27 (supplementary ﬁ  gure 1A,B).
Immunohistochemistry
Synovial membrane (SM) biopsies were snap frozen in OCT 
compound (Tissue Tek, Sakura, Zoetrewoude, The Netherlands). 
Cryostat sections 7 μm thick were cut, placed on glass slides 
coated with 2% 3-amino-propyl-triethoxy-silane (Sigma-
Aldrich, Dublin, Ireland). Synovial biopsies were also ﬁ  xed in 
10% formalin and embedded in parafﬁ  n. Biopsy sections 3 μm 
thick were cut and mounted onto SuperFrost Plus adhesive slides 
(Menzel-Glaser, Braunschweig, Germany).
For immunohistological staining (CD3, CD68 and Ki67) tis-
sue sections were allowed to reach room temperature, ﬁ  xed in 
acetone for 10 min and air dried. A routine three-stage immu-
noperoxidase labelling technique incorporating avidin–biotin–
immunoperoxidase complex (Dako, Glostrup, Denmark) was 
used. The sections were incubated with primary antibodies 
against mouse monoclonal CD3, CD68 and Ki67 (Dako) at 
room temperature. Sections were also incubated with an irrel-
evant isotype matched control. Colour was developed in solu-
tion containing diaminobenzadine-tetrahydrochloride (Sigma, 
St Louis, Missouri, USA), 0.5% H2O2 in phosphate-buffered 
saline buffer (pH 7.6). Slides were counterstained with haema-
toxylin and mounted.
The presence of apoptosis DNA fragmentation was assessed 
in situ by terminal deoxynucleotidyl transferase (TdT)-mediated 
dUTP nick end labelling (TUNEL) assay (ApopTag Plus Peroxidase 
In Situ, S7101; Chemicon, Millipore, Billerica, Massachusetts, 
USA). Tissue sections were deparafﬁ  nised in xylene, followed 
by ethanol and subsequently pretreated with proteinase K. After 
quenching with endogenous peroxidase, equilibration buffer 
was carefully applied. Terminal deoxynucleotidyl transferase 
(TdT) enzyme was applied and incubated for 1 h at 37°C. After 
stop/wash buffer, antidigoxigenin conjugate was applied and 
incubated for 30 min at room temperature followed by incu-
bation with peroxidase substrate for approximately 3 min. The 
slides were counterstained with haematoxylin and mounted.
CD3, CD68, Ki67 and TUNEL coded slides were analysed 
by two blinded operators using an established semiquantitative 
scoring method (0–4) (0=no staining, 1≤25%, 2=25% to 50%, 
3=50% to 75%, 4≥75% staining).30 Sections were scored sepa-
rately for lining and sublining layer. Lining layer thickness was 
scored as previously described.31
Primary synovial ﬁ  broblasts
Primary synovial ﬁ  broblasts (SFCs) were isolated from syno-
vial biopsies obtained from patients who had undergone hyp-
oxic measurements at arthroscopy. Enzymatic digestion of 
synovial biopsy specimens was carried out with 1 mg/ml of 
type I collagenase (Worthington Biochemical, Lakewood, New 
Jersey, USA) in RPMI (Gibco BRL, Paisley, UK) for 4 h at 37°C 
in humidiﬁ  ed air with 5% CO2. Dissociated cells were plated 
in RPMI 1640 supplemented with 10% fetal calf serum (FCS; 
Gibco BRL), 20 mM 4-(2-hydroxyethyl)-1-piperazineethanesul-
fonic acid (HEPES) (Gibco BRL), penicillin (100 units/ml), strep-
tomycin (100 units/ml) and Fungizone (0.25 μg/ml) (Biosciences, 
Plymouth, Minnesota, USA). Cells were grown to conﬂ  uence 
and used between passages 3 and 6.
K4IM Cell line
An immortalised normal human synoviocyte cell line (K4IM) 
(kind gift from Dr Evelyn Murphy , Vetinary College, University 
College Dublin, Dublin, Ireland) was used to examine the effects 
of conditioned media obtained from primary SFCs under nor-
moxic and hypoxic conditions. Cells were cultured in RPMI 1640 
supplemented with 10% FCS (Gibco BRL , Invitrogen, Carlsbad, 
California, USA), 20 mM HEPES (Gibco BRL), penicillin (100 
units/ml), streptomycin (100 units/ml) and Fungizone (0.25 μg/
ml). The cells were incubated and grown to conﬂ  uence.
To examine the effect of hypoxia on cell migration SFCs 
obtained from three patients, on whom in vivo hypoxia mea-
surements  had been recorded and K4IM, were cultured in 
triplicate and exposed to the tPO2 measurements obtained at 
arthroscopy to mimic the in vivo joint environment. Primary 
SFCs were seeded onto 24-well plates and allowed to come to 
conﬂ  uence. A single scratch wound was induced through the 
middle of each well with a sterile pipette tip. Cells were subse-
quently exposed to normoxia, 1% oxygen and the in vivo tPO2 
level for each patient. Two patients had in vivo measurements 
of approximately 3% and the other of approximately 5% oxy-
gen. SFC migration across the wound margins from 12 to 24 
h was assessed and photographed. To further examine the role 
of hypoxia on the microenvironment, K4IM were seeded onto 
24-well plates and allowed to reach conﬂ  uence. A single scratch 
wound was induced and cells were incubated with conditioned 
media obtained from the primary SFC cultures following expo-
sure to hypoxia. K4IM migration across the wound margins was 
assessed as described above.
Cytokine measurements
In matched serum and SFCs TNFα, interleukin 1β (IL1β), IL6, 
interferon γ (IFNγ) and macrophage inﬂ  ammatory protein 3α   
(MIP3α)  were quantiﬁ  ed by MSD multiplex assay, IL8 was 
quantiﬁ  ed by ELISA (R&D Systems).
Statistical analysis
SPSS V.11 for Windows (SPSS, Chicago, Illinois, USA) was used 
for statistical analysis. Non-parametric Wilcoxon signed-rank 
test and Spearman correlation coefﬁ  cient were used for analy-
sis. p Values of less than 0.05 were considered to be statistically 
signiﬁ  cant. Data was expressed as median (range), unless other-
wise speciﬁ  ed.
RESULTS
Patients
A total of 30 participants (21 with RA, 9 with PsA) with inﬂ  amma-
tory arthritis were recruited for this study. The median age was 
52.84 (27.26–80.22) years. All patients had clinically active dis-
ease, including tender joint count: 5 (0–28), swollen joint count: 6 
(1–9), ESR: 23 (2–74) mm/h, CRP: 21 (4–99) mg/l, 28-joint Disease 
Activity Score (DAS28): CRP 4.0 (2.76–6.89), VAS: 46 (0–84) mm 
and disease duration: 54 (6–564) months. The number (%) of Extended report
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In vitro graded hypoxia-induced cell migration mimicking in vivo 
joint environment
Induction of SFC migration across a wound in 24-well culture 
plates was assessed under normoxic and hypoxia conditions. 
Figure 4A shows representative images demonstrating three SFC 
wounds exposed to normoxia, their in vivo tPO2 measurements 
(3% or 5%) and 1% oxygen as a positive control. Wound repair 
was assessed by the amount of cells migrating across the wound 
through direct visualisation using light microscopy (ﬁ  gure 4A). 
The ﬁ  rst two patients had in vivo tPO2 levels of approximately 
3%, exposure of their SFCs to 3% oxygen-induced cell migra-
tion across the wound compared to normoxia. We found no 
effect when the third patient’s SFC were exposed to 5% oxygen 
(in vivo measurement), however induction was demonstrated 
at 1%, suggesting a graded hypoxic effect. Figure 4B demon-
strates representative images of K4IM migration following incu-
bation with conditioned media obtained from one of primary 
synoviocyte cultures exposed to normoxia, 1%, or 3% oxygen. 
Conditioned media-induced morphological cellular changes of 
K4IM, with 1% and 3% inducing K4IM migration. These exper-
iments show a graded hypoxia effect on synoviocyte migration 
mimicking that of the in vivo environment.
Relationship of in vivo tPO2 with cytokines and chemokines
SF levels were signiﬁ  cantly higher compared to matched serum 
for TNFα (24.5 vs 48.3, p=0.0074), IL1β (4.64 vs 37.11, p=0.001), 
IL6 (20.57 vs 1384.95, p=0.0001), IFNγ (38.88 vs 107.1, p=0.001), 
IL8 (27.87 vs 555.51, p=0.001) suggesting localised production of 
these cytokine/chemokines at the site of inﬂ  ammation. When 
results are categorised into those with tPO2<or>20 mm  Hg, 
SF but not serum levels of TNFα, IL1β, IFNγ and MIP3α were 
patients with circulating antibodies that were rheumatoid factor 
positive was 14 (47%), and anti-CCP positive 14 (47%).
Relationship between in vivo tPO2 and inﬂ  ammation
Macroscopic synovitis levels were 60 mm (4–100). Quantiﬁ  cation 
of tPO2 demonstrates signiﬁ  cant, and variable, levels of hypoxia 
22.5 (3.2–54.1) mm  Hg consistent with ambient oxygen ten-
sions of 3.2% (0.45–7.7) (see supplementary ﬁ  gure 1). Paired 
SF pO2 measurements were higher than tPO2 levels, at 29.5 
mm Hg (2–65), no relationship was found between joint ﬂ  uid 
volume and hypoxia. Normal ST pO2 level was 39.9 mm Hg. 
Figure 1A shows representative images of macroscopic synovitis 
from patients with low, medium and high tPO2 levels, demon-
strating that patients with low tPO2 have higher synovitis. The 
tPO2 levels signiﬁ  cantly correlated with macroscopic synovitis 
(r=−0.421, p=0.02) (ﬁ  gure1B) and DAS28 (r=−0.412, p=0.026, 
indicating higher levels of inﬂ  ammation are signiﬁ  cantly associ-
ated with a more hypoxic environment. Representative images 
of CD3 and CD68 staining from patients with low, medium and 
high tPO2 levels are demonstrated in ﬁ  gure 2A,C. A signiﬁ  cant 
correlation was demonstrated between microscopic CD3 cell 
sublining expression and tPO2 (r=−0.611, p<0.01) (ﬁ  gure  2B) 
and between microscopic CD68 cell sublining tPO2 (r=−0.613, 
p<0.01) (ﬁ   gure 2D), demonstrating an inverse relationship 
between tPO2 levels and cell inﬁ  ltration in the inﬂ  amed joint. 
While there is an inverse association between tPO2 and lining 
layer thickness (r=−0.368, p=0.059) this did not reach signiﬁ  -
cance. Figure 3 demonstrates representative images of Ki67 (A) 
and TUNEL (B) staining, which had no association with pO2 
levels, consistent with the hypothesis of impaired apoptotic 
pathways in the inﬂ  amed microenvironment.
Figure 1  A. Representative images of macroscopic synovitis in patients with low, moderate and high measures of in vivo tissue PO2 (tPO2) levels. 
B. Scattergraph demonstrating the inverse correlation between tPO2 and macroscopic synovitis. r, Spearman’s correlation coefﬁ  cient, p<0.05 is 
statistically signiﬁ  cant.Extended report
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signiﬁ  cantly higher in patients with lower tPO2 measurements 
(ﬁ  gure 5A–D). No signiﬁ  cant difference for SF IL6 and IL8 lev-
els was observed. Sublining CD3 cells signiﬁ  cantly correlated 
with SF TNFα (r=0.558, p=0.009), IL1β (r=0.478, p=0.033), IFNγ 
(r=0.51, p=0.03) and IL8 (r=0.621, p=0.031), suggesting a direct 
link between local expression of proinﬂ  ammatory  mediators 
and T cell inﬁ  ltration, there was no signiﬁ  cant difference in cel-
lular inﬁ  ltrate between RA and PsA.
DISCUSSION
In this study we demonstrate low tPO2 levels in the inﬂ  amed 
synovial joint tissue are signiﬁ  cantly associated with increased 
markers of macroscopic and microscopic inﬂ  ammation, 
including soluble mediators. In particular, we demonstrate a 
signiﬁ   cant association of tPO2  with macroscopic synovitis, 
microscopic CD3 and CD68 cell inﬁ   ltrate in the sublining 
and proinﬂ   ammatory cytokines (TNFα, IL1β, IFNγ and the 
chemokine MIP3α), changes independent of proliferation and 
cell death. There was an inverse relationship between tPO2 and 
lining layer thickness, however this did not reach signiﬁ  cance. 
Finally, in vitro primary SFCs exposed to pO2 levels, reﬂ  ect-
ing those measured in vivo in the joint, showed a signiﬁ  cant 
increase in cell migration.
The hypothesis that the inﬂ  amed joint is a hypoxic environ-
ment was originally suggested based on synovial cavity or SF 
measurements. Lund-Olesen, in 1970, used a Clark-type elec-
trode in SF to demonstrate SF pO2 in RA knee joint (26.53 mm Hg) 
was signiﬁ  cantly lower than in OA (42.92 mm Hg) or traumatic 
effusions (63 mm Hg),17 which was consistent with subsequent 
studies.18 This was supported by studies showing increased 
Figure 2  Microscopic synovitis and tissue PO2 (tPO2). A,C. Representative images of immunohistochemical staining for CD3 and CD68, in lining 
and sublining layers, from patients with low, moderate and high in vivo tPO2 levels. B,D. The correlation between tPO2 and CD3 and CD68 staining in 
synovial sublining layers. r, Spearman’s correlation coefﬁ  cient, p<0.05 is statistically signiﬁ  cant.
Figure 3  Ki67 and terminal deoxynucleotidyl transferase dUTP nick end labelling (TUNEL) staining in synovial tissues. A,B. Representative images 
of immunohistological staining for Ki67 (top panel) and TUNEL (lower panel), in lining and sublining layers, in patients with low, moderate and high in 
vivo tissue PO2 (tPO2) levels, demonstrating low expression indices of both markers.Extended report
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Figure 4  Migration assays in primary and normal synoviocytes. A. Representative images of primary synoviocytes wound repair assays exposed to 
normoxia (n=3), in vivo oxygen levels (n=2 at 3%, n=1 at 5%), and positive control of 1% oxygen for 24 h. Signiﬁ  cant migration was observed when 
primary synoviocytes (patients 1 and 2) were exposed to 3% when compared to normoxia (A, left and middle panels), an effect that was greater at 
1% hypoxia. When primary synovial ﬁ  broblast cells (SFCs) were exposed to 5% hypoxia (patient 3) migration was minimal and similar to normoxia 
(A right panel), migration was demonstrated when exposed to 1%. B. Normal synoviocytes cultured in conditioned supernatant from primary SFCs 
exposed to normoxia, 3% and 1% oxygen for 24 h before scratches. Signiﬁ  cant migration was observed in those incubated with conditioned media 
from 1% and 3% hypoxic conditions. CM, cultured media; N, normoxia.
Figure 5  Proinﬂ  ammatory cytokines/chemokines in synovial ﬂ  uid and tissue PO2 (tPO2). A–D. Signiﬁ  cant differences in tumour necrosis factor (TNF)
α, interleukin (IL)1β, interferon (IFN)γ and macrophage inﬂ  ammatory protein (MIP)3α levels between patients with tPO2 values of greater or less than 
20 mm Hg. p<0.05 was signiﬁ  cantly different. E,F. No signiﬁ  cant differences in IL6 and IL8 levels between patients with tPO2 values of greater or less 
than 20 mm Hg.Extended report
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rheumatoid arthritis synovial ﬂ   uid show no apoptosis12 and 
hypoxia appears to reduce apoptosis in synovial neutrophils.46 
Recently, Wijbrandts et al showed no evidence of increased 
apoptosis in RA peripheral blood mononuclear cell following 
inﬂ  iximab treatment, suggesting the rapid decrease in synovial 
cellularity is the result of reduced cell migration and retention.47 
A dissociation between invasion and proliferation in RA SFCs 
in vitro has been reported13 conferring a survival advantage to 
synoviocytes which may result from impaired apoptotic path-
ways, including somatic mutations in p53.48 Hypoxia can induce 
antiapoptotic pathways in synoviocytes, an effect inhibited by 
TNFα and IL1β.49 In this context, our data support the hypothe-
sis of a complex hypoxic microenvironment, with enhanced cell 
migration and reduced apoptosis which may maintain a chronic 
inﬂ  ammatory response.
Hypoxia may result from high metabolic demand, how-
ever raised intra-articular pressures during movement or joint 
swelling,50 may also compromise synovial vascular supply fur-
ther exacerbating the hypoxic environment.51 In a mouse model 
of arthritis, markers of hypoxia were observed in synovium at 
the preclinical stage, and positively correlated with synovitis, 
suggesting hypoxia is a primary event.
In summary, we have shown, for the ﬁ  rst time, that tPO2 
signiﬁ   cantly correlates with macroscopic and microscopic 
inﬂ  ammation, local production of proinﬂ  ammatory cytokines, 
chemokines and cell migration. These data provide evidence 
suggesting that hypoxia may be an initiating factor in driving 
synovial inﬂ  ammation.
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glycolytic metabolism in the joint suggestive of increased meta-
bolic activity.18 32 33 More recently, Sivakumar et al, demonstrated 
low pO2 levels in patients with RA undergoing surgical tendon 
repair, in ST and tenosynovium, the latter being more hypoxic, 
suggesting different gradients of hypoxia may exist within the 
tissues.21 Using a novel probe we have recently demonstrated 
low levels of pO2 in synovial membrane under direct visualisa-
tion at arthroscopy.26 27 The present data provide the ﬁ  rst direct 
evidence that the level of hypoxia is signiﬁ  cantly associated 
with the degree of synovitis in the joint, with low tPO2 levels 
associated with increased macroscopic synovitis. The level of 
tissue pO2 demonstrated in the joint and its correlation with 
severity of intra-articular inﬂ  ammation suggests a speciﬁ  c effect 
and highlights the heterogeneity of the local inﬂ  ammatory envi-
ronment in the joints of patients with arthritis.
To further strengthen our ﬁ  ndings we show direct evidence 
for the ﬁ  rst time that tPO2 levels signiﬁ  cantly correlate with 
CD3T and CD68 macrophages in the synovial sublining. tPO2 
levels were also associated with lining layer thickness, however 
this did not reach signiﬁ  cance. T lymphocytes and macrophages 
play a critical role in the initiation and perpetuation of syno-
vial inﬂ  ammation and are potent producers of proinﬂ  ammatory 
mediators, which drive angiogenesis, cell adhesion, migration 
and invasion. Furthermore studies have shown that CD3 and 
CD68 sublining expression correlate with disease activity,34 35 
and have been hypothesised as speciﬁ  c tissue biomarkers of 
response to treatment in RA.36 In addition, we have shown 
using an in vitro wound assay, that hypoxia stimulates SFC 
migration. Together these results suggest that hypoxia induces 
cell migration into the joint and may be important in determin-
ing the invasiveness of the synovial pannus. This is consistent 
with studies suggesting that during the inﬂ  ammatory response, 
expansion of the synovium is greater than the oxygen supply.16 
Low pO2 levels coupled with altered vascularity supports a 
role for hypoxia in driving inﬂ  ux of inﬂ  ammatory cells into the 
joint.26 27 The data in the current study also extend our previ-
ous observations to suggest that hypoxia may drive intracellular 
upstream pathways such as oxidative stress and lipid peroxida-
tion resulting in DNA damage.26 27
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